Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC1R | Q01726 | 9/20 | 1.00 |
| ▸ | MC4R | P32245 | 9/20 | 0.71 |
| ▸ | MC5R | P33032 | 1/20 | 0.40 |
| ▸ | MC3R | P41968 | 1/20 | 0.40 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.38 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.35 |
| ▸ | CCR2 | P41597 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.34 |
| ▸ | PDE5A | O76074 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL1310554 | 0.96 | MC1R (0.92) | MC1RMC4RMC5RMC3RP2RY12 | |
| SCHEMBL1310555 | 0.89 | MC1R (0.80) | MC1RMC4RMC5RMC3RP2RY12 | |
| SCHEMBL20450442 | 0.89 | MC1R (0.79) | MC1RMC4RMC5RMC3RP2RY12 | |
| SCHEMBL1309721 | 0.89 | MC1R (0.79) | MC1RMC4RMC5RMC3RP2RY12 | |
| SCHEMBL16445351 | 0.85 | MC1R (0.73) | MC1RMC4RP2RY12 | |
| SCHEMBL2154492 | 0.83 | MC1R (0.70) | MC1RMC4RMC5RMC3RP2RY12 | |
| SCHEMBL1310558 | 0.82 | MC1R (0.69) | MC1RMC4RHRH4 | |
| SCHEMBL2155532 | 0.80 | MC1R (0.65) | MC1RMC4RMC5RMC3R | |
| SCHEMBL20450363 | 0.78 | MC1R (0.73) | MC1RMC4RMC5RMC3R | |
| SCHEMBL1311193 | 0.78 | MC1R (0.73) | MC1RMC4RMC5RMC3R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2342194-B1 | OXOAZETIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS | GALDERMA RES & DEV (FR) | 2018-08-08 | — | — | EP | claimed |